Dr Carmela Ciardullo
Dr Katarzyna Szoltysek
Dr Peixun Zhou
Dr Elaine Willmore
Dr Amir Enshaei
et al. | Low BACH2 expression predicts adverse outcome in chronic lymphocytic leukaemia | 2022 |
|
Amanda Lavinya
Dr Emmanuel Moses
Dr Meera Soundararajan
Dr Jeyanthy Eswaran
| Homozygous Southeast Asian Ovalocytosis in five live-born neonates | 2021 |
|
Dr Katarzyna Szoltysek
Dr Carmela Ciardullo
Dr Peixun Zhou
Dr Anna Walaszczyk
Dr Elaine Willmore
et al. | Dap kinase-related apoptosis-inducing protein kinase 2 (Drak2) is a key regulator and molecular marker in chronic lymphocytic leukemia | 2020 |
|
Dr Joanna Elson
Dr Meera Soundararajan
Dr Ilse Pienaar
| Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease | 2020 |
|
Dr Daniel Peters
Dr Jeyanthy Eswaran
Professor Jeremy Lakey
Dr Meera Soundararajan
| Human Miro Proteins Act as NTP Hydrolases through a Novel, Non-Canonical Catalytic Mechanism | 2018 |
|
Dr Carmela Ciardullo
Dr Peixun Zhou
Dr Elaine Willmore
Professor Christine Harrison FRCPath FMedSci
Dr Andrew Hall
et al. | Impact of the apoptotic regulator DRAK2 in chronic lymphocytic leukemia | 2016 |
|
